New artificial intelligence (AI) software that helps providers diagnose fractures and traumatic injuries on radiographs has been given the green light by the U.S. Food and Drug Administration (FDA). 

Gleamer, a French company that specializes in the development of AI software in the radiology space, announced the FDA clearance of its BoneView AI software in a press release earlier this week. 

“In the value-based U.S. health care system, providers tell us they want to improve the radiographic diagnostic process, which accounts for a huge part of their workload, and optimize patient…